These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24117728)

  • 1. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.
    Schwimmer JB; Newton KP; Awai HI; Choi LJ; Garcia MA; Ellis LL; Vanderwall K; Fontanesi J
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1267-77. PubMed ID: 24117728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease.
    Lu Y; Wang Q; Yu L; Yin X; Yang H; Xu X; Xia Y; Luo Y; Peng Y; Yu Q; Chen Z; Yu J; Lai M; Wu N; Pan XB; Zheng X
    J Clin Lab Anal; 2020 Jul; 34(7):e23285. PubMed ID: 32267017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
    El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
    Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents.
    Ezaizi Y; Kabbany MN; Conjeevaram Selvakumar PK; Sarmini MT; Singh A; Lopez R; Nobili V; Alkhouri N
    JHEP Rep; 2019 Oct; 1(4):259-264. PubMed ID: 32039376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
    Simental-Mendía LE; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1173-7. PubMed ID: 22735606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.
    Schwimmer JB; Dunn W; Norman GJ; Pardee PE; Middleton MS; Kerkar N; Sirlin CB
    Gastroenterology; 2010 Apr; 138(4):1357-64, 1364.e1-2. PubMed ID: 20064512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
    Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of non-alcoholic fatty liver disease in overweight and obese children seeking ambulatory healthcare in Nairobi, Kenya.
    Mburu AN; Laving A; Macharia WM; Sande J
    BMJ Open Gastroenterol; 2023 Feb; 10(1):. PubMed ID: 36796875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.
    Fu CC; Chen MC; Li YM; Liu TT; Wang LY
    Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease.
    Kraus EM; Pierce SL; Porter R; Kompaniyets L; Vos MB; Blanck HM; King RJ; Goodman AB
    Child Obes; 2024 Jan; 20(1):41-47. PubMed ID: 36862137
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
    Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings.
    de Silva MHAD; Hewawasam RP; Kulatunge CR; Chamika RMA
    BMC Pediatr; 2022 Aug; 22(1):511. PubMed ID: 36042456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018.
    Abrams GA; Rabil AM; Williams AP; Hecht EM
    Clin Pediatr (Phila); 2021 Jul; 60(8):370-375. PubMed ID: 34100658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
    Reinehr T; Schmidt C; Toschke AM; Andler W
    Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.